|
Tuesday, September 23, 2014 |
RedChip Money Report
|
|
Table of Contents - Quick Links:
Quote of the Week
"Invest in something you can get your arms around and be very conservative, own enough stock so that you are not putting all your eggs in one basket." -Dave Maley
Featured This Week
GlyEco Sets Stage for Expansion at New Jersey Processing Center With Receipt of Class D Recyclable Materials Permit
GlyEco (OTC QB: GLYE) was issued a Class D Recyclable Materials ("Class D") permit by the State of New Jersey Department of Environmental Protection ("NJ DEP"), Division of Solid and Hazardous Waste and Bureau of Recycling Hazardous Waste Management in Trenton, NJ.
"We are honored to receive the Class D permit in New Jersey," stated John Lorenz, Chairman and CEO of GlyEco. "The operating and documentation requirements to process material under this permit are rigid and thorough. We believe our customers benefit from operating under these guidelines, and it will help us create more opportunities for glycol recycling in the expansive Northeast region." Read More | Learn about GLYE
|
| |
 |
 |
 |
 |
 |
 |
Quadrant 4 Systems
(OTC QB: QFOR) |
8/12/2013 |
$0.06 |
$1.38 |
$0.54 |
802% |
2,200% |
Inovio Pharmaceuticals
(NYSE-MKT: INO) |
11/17/2012 |
$1.96 |
$15.28 |
$10.22 |
421% |
680% |
Profire Energy
(NasdaqCM: PFIE) |
8/07/2013 |
$1.40 |
$5.78 |
$4.18 |
199% |
313% |
Galectin Therapeutics
(NasdaqCM: GALT) |
6/13/2012 |
$2.00 |
$18.30 |
$5.28 |
164% |
815% |
Blue Earth, Inc.
(OTC BB: BBLU) |
11/02/2011 |
$1.24 |
$3.74 |
$3.20 |
158% |
202% |
Craft Brew Alliance
(NasdaqGS: BREW) |
12/15/2012 |
$6.49 |
$17.78 |
$13.42 |
107% |
174% |
MusclePharm
(OTC QB: MSLP) |
2/08/2013 |
$6.49 |
$13.80 |
$13.25 |
104% |
113% |
Giggles n' Hugs
(OTC QB: GIGL) |
5/06/2014 |
$0.28 |
$1.43 |
$0.57 |
104% |
411% |
InterCloud Systems
(NasdaqCM: ICLD) |
11/11/2013 |
$2.47 |
$18.36 |
$4.28 |
73% |
643% |
Northwest Biotherapeutics
(NasdaqCM: NWBO) |
2/23/2013 |
$3.30 |
$9.18 |
$5.45 |
65% |
178% |
Asure Software
(NasdaqCM: ASUR) |
12/12/2011 |
$3.17 |
$7.91 |
$5.18 |
63% |
150% |
Trecora Resources
(NYSE: TREC) |
3/23/2013 |
$8.32 |
$13.39 |
$12.97 |
56% |
61% |
Galaxy Gaming, Inc.
(OTC BB: GLXZ) |
6/13/2013 |
$0.27 |
$0.50 |
$0.40 |
48% |
85% |
American Water Works
(NYSE: AWK) |
1/19/2013 |
$37.91 |
$50.61 |
$49.25 |
30% |
34% |
Lightbridge
(NasdaqCM: LTBR) |
10/15/2012 |
$2.00 |
$3.75 |
$2.49 |
25% |
88% |
BDCA Venture
(NasdaqCM: BDCV) |
4/27/2013 |
$3.95 |
$7.30 |
$4.85 |
23% |
85% |
Xplore Technologies
(NasdaqCM: XPLR) |
12/05/2012 |
$4.30 |
$7.30 |
$5.27 |
23% |
70% |
OxySure Systems, Inc.
(OTC QB: OXYS) |
9/02/2014 |
$0.72 |
$0.83 |
$0.83 |
15% |
15% |
Digital Cinema Destinations
(NasdaqCM: DCIN) |
7/02/2013 |
$5.49 |
$6.78 |
$5.99 |
9% |
23% |
Lattice, Inc.
(OTC QB: LTTC) |
8/28/2012 |
$0.08 |
$0.23 |
$0.08 |
2% |
188% |
* Data as of 9/21/2014 19:09
Sector News
Biotechnology
Actinium Pharmaceuticals (NYSE MKT: ATNM)
Actinium to Present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26th
Read MoreBiocept (NasdaqCM: BIOC)
Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating Tumor Cells
Read MoreHealth Enhancement Products, Inc (OTCQB: HEPI)
Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting
Read MoreInovio Pharmaceuticals (NYSE-MKT: INO)
Inovio to Present at Upcoming Investor Conferences
Read MoreInovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
Read MoreOpexa Therapeutics (NasdaqCM: OPXA)
Opexa Therapeutics, Inc. Announces Termination of Public Offering of Common Stock
Read MoreRedHill Biopharma Ltd. (NasdaqCM: RDHL)
RedHill Biopharma to Present at the 14th Annual Biotech In Europe Forum for Global Partnering & Investment
Read More
Consumer Goods
iSatori (OTC QB: IFIT)
iSatori Announces Appointment of Seth Yakatan as Newest Addition to Board of Directors
Read MoreMusclePharm (OTC QB: MSLP)
MusclePharm Enters Into $8 Million Credit Facility
Read MoreMusclePharm Launches CocoProtein(TM) Sports Drink at Mr. Olympia Expo
Read More
Energy
Methes Energy (NasdaqCM: MEIL)
Methes Energies Attracts Large Response to Recent Successful Webinar
Read More
Health Care
Akers Biosciences, Inc. (NasdaqCM: AKER)
Akers Biosciences Features on Global Broadcast & Online Media
Read MoreBoston Therapeutics (OTC QB: BTHE)
Boston Therapeutics to Present Findings of BTI-320 as Therapy for Glycemic Control at 50th Annual Meeting of European Association for the Study of Diabetes
Read MoreBoston Therapeutics Signs Clinical Trial Agreement With Prestigious Joslin Diabetes Center for Phase III Study of BTI-320
Read MoreNorthwest Biotherapeutics (NasdaqCM: NWBO)
NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM)
Read MoreOxySure Systems, Inc. (OTC QB: OXYS)
OxySure (OXYS) Selected by USPTO to Exhibit OxySure Model 615 and Related Technologies at Innovation Expo at Smithsonian
Read MoreOxySure (OXYS) Welcomes Clark Hood as Vice President, Resuscitation Sales Worldwide
Read More
Industrials
GlyEco (OTC QB: GLYE)
GlyEco Sets Stage for Expansion at New Jersey Processing Center With Receipt of Class D Recyclable Materials Permit
Read More
Mining & Metals
Trecora Resources (NYSE: TREC)
Trecora Resources to Present at Singular Research's 9th Annual "Best of the Uncovereds" Conference on September 22, 2014
Read MoreTrecora Resources agrees to acquire SSI Chusei, Inc.
Read More
Social Media
MeetMe (NasdaqCM: MEET)
Technology
Bitcoin Shop, Inc. (OTC QB: BTCS)
Gem Raises $2M to Empower the Next Wave of Developers With Simple Yet Secure Bitcoin Platform
Read MoreBitcoin Shop Announces Previous Strategic Investment in Cloud Wallet Storage Service, Gem
Read MoreBlue Earth, Inc. (OTC BB: BBLU)
Blue Earth to Purchase Equity Position in PowerGenix With $10 Million Dollar Investment
Read MoreSeeThruEquity Initiates Research Coverage on Blue Earth, Inc. with Target Price of $4.43
Read MoreDRONE Aviation Corp (OTCQB: DRNE)
Drone Aviation Completes Delivery of Advanced Day/Night Optics Package to State Agency Customer
Read MoreLattice, Inc. (OTC QB: LTTC)
Winkler County Texas Chooses Lattice's ICON Platform
Read MorePerceptron (NasdaqGM: PRCP)
Perceptron(R) Launches Helix(TM) Advantage Solutions(TM)
Read MoreVeriTeQ (OTC QB: VTEQ)
Utilities
American Water Works (NYSE: AWK)
California American Water Awarded $1 Million State Grant for Desalination Test Well
Read MoreAmerican Water Declares Quarterly Dividend
Read More
Commodities Report by Paul Lengemann
Paul Lengemann is an economic and political analyst with 37 years of experience in economic, financial and political research. Mr. Lengemann operates FXLiveTV, a foreign exchange information portal.
Gold
Gold has lost its attraction for most money managers. Friday ended the week under pressure, continuing the mode of the month. Spot gold opened September on the COMEX at 1286 and is currently down 5.5% for the month. With the geopolitical trouble spots failing to disrupt the world economies and the stability of the US, fund managers have been looking for places for better returns without fear for safety.
The USD seems to have more upside as traders plow into US equities and treasuries. The strength in the US markets seems to be coming from weakness in others. The Chinese economy has lost its luster and those worries are driving investors back. Ironically, the Shanghai Gold Exchange opened to the world last week in an effort to gain better control of pricing just as the investor capital is moving away from both China and gold. In the meantime this new venue should make supply and demand figures from China more transparent.
Technically, spot gold prices are still probing the downside for a bottom. The current price has not been seen since the first of the year. With 1204 the current 2014 low, sell stops should be expected waiting below that level with the twice tested 1180 support level in the sights of most traders. Any bulls will need a close above 1224 to find hope in an upside move.
Silver
Silver keeps following gold. It opened in New York today at $17.69 per ounce.
Crude
West Texas Intermediate was steady in New York. Brent crude declined for the third time in four days after China’s finance minister damped speculation that the government will boost economic stimulus.
Small-Cap Lesson of the Week:
Dave Maley's Message to Investors
Invest in something you can get your arms around and be very conservative, own enough stock so that you are not putting all eggs in one basket. If you don't have time to devote to doing your own homework, better to have someone manage your accounts for you. There are a lot of risky companies built on one or two products, be wary of those. Be wary of bad management teams, don't bet on dreams. Do your homework and be careful.
-Dave Maley
MidSouth Week In Review
Weekly Update from Fund Manager Buzz Heidtke, MidSouth Investment Fund
Chinese online e-commerce company Alibaba (BABA - $93.89) IPO’ed today at $68 a share, before closing at $93.89 ,making founder Jack Ma the richest man in China. After twice failing the national college entrance exams, Ma was accepted in what he called the “worst college.” The 49 year-old, five-foot Ma had failed math but loved English and taught it at a local college for five years at $15 a month. The current valuation of Alibaba is $230 billion vs. Microsoft ($387 bil), FaceBook ($201 bil), Walmart ($247 bil), Chevron ($237 bil), and Yahoo ($40 bil).
BuzzBits
-
Stay the Course - The typical mutual fund investor had a 3.69% annualized return over the past 30 years and 0.7% for those in bond funds. Yet someone fully invested in the S&P 500 over the period would have earned eight times as much as a typical equity-fund investor. Results for bonds were similar - Dalbar
-
Democracy - is the worst form of government ever tried - except for all the others - Winston Churchill
-
Ouch! - Many long time holders of Nashville-based Life & Casualty and National Life, that eventually became AIG, were told to never sell their stock because they had little or no cost basis. Bad decision regarding saving on taxes. A $1,000,000 holding in the stock in 2007 is now worth only $46,000, a 95.4% decline from the top - Buzz
-
College Blues - The University of North Carolina’s higher education system that includes N.C. State, said in February it would lose $47 million to insure 8,586 employees (ObamaCare) who clock at least 30 hours but previously weren’t qualified for benefits. NC State responded with a policy that restricts undergrads to 20 hours per week and the other employees to 29 - Investor’s Business Daily
-
NASDAQ Bear Market - Around 47% of NASDAQ stocks are down at least 20% from their peak in the last 12 months, while more than 40% of the small cap Russell 2000 stocks have had similar declines - Bloomberg
-
300-Pounders - The Green Bay Packers largest player in Sugar Bowl I in 1967 weighed 260 pounds. By 2010 there were 532 300-pounders in training camps. Last week the NFL Players Association approved new policies on substance abuse, which included testing this season for human growth hormones. My prediction is that NFL players in the 300 pound category will drop as fast as the recent home run production in major league baseball - Buzz
-
Ferguson, MO - The city issued about 25,000 arrest warrants last year. Three per household, according to Arch City Defenders. The city of 24,000 has nearly 12,000 people with pending arrest records - New York Times
-
From Top To Bottom - Ex Atlanta Brave Chipper Jones was spotted at the airport scavenging the trash bin, apparently looking for food. When asked by someone if they could help him, Jones replied, “No, I lost my cell phone and thought I might have thrown it in the trash with my discarded breakfast.” - USA TODAY
-
Former CNBC Watchers - Stocks may be at record highs, but viewers aren’t getting their market info from financial news cable network CNBC. For the core 25-54 demographic, CNBC’s “Business Day” segment is down every month this year compared with last year, with August’s 280,000 viewership 30% below the same month a year earlier, according to Nielsen ratings - Associated Press
-
Student Loan Debts - More than 2 million Americans age 60+ are carrying student debt, up from 700,000 in 2005. What many don’t know, the government has the power to seize portions of Social Security checks of those who’ve stopped paying their federal student loans. 10.9% of student loan debt is in default vs. 8.9% in 2012 - Federal Reserve Bank of New York
-
Colorado Tax Windfall? - The state began allowing the sale of marijuana this January after 55% of its voters backed the bill. Only problem is that the state is now projecting only $30.6 million in tax revenue this year from the sale of “pot” vs. the $70 million the backers of the bill projected - Tax Foundation
-
Denver quarterback, Peyton Manning - didn’t fare too badly following the legalization of marijuana in the state. Manning picked up 21 Papa John’s franchises in the Denver area just before the state passed a legalization amendment in 2012. The stores raked in record sales in the 2013 post-legalization period, registering a 25% profit increase at one location - www.Bleacherreport.com
-
Inheritances - 32% of Americans say they have inherited money, averaging $69,000. 38% of households earning $250,000+ have received inheritances vs. 17% of those making less than $15,000 - www.FiveThirtyEight.com
-
Want to Get Rich? - Step 1: Ignore your Mother - Inc.com www.inc.com/john-warrillow/want-to-get-rich-start-by-ignoring-your-mom-s-advice.html?cid=sf01001
RedChip Conferences
More than 8,000 investors have attended our RedChip Global Online CEO Conferences this year. Don't miss your chance to listen to leading small-cap company executives provide detailed overviews of their businesses through video presentations and live Q&A sessions.
Be sure to visit the October conference page today to see the full schedule of presenting companies, and mark your calendar for October 15-16 so you don’t miss our industry leading online conference.
Weekly Notes from Paul Resnik, RedChip CFA
Paul Resnik operates Resnik Asset Management Co. (RAMCO), a registered investment advisor.
Overview
U.S. stocks finished the week slightly higher despite of, or perhaps because of, worrisome developments in Ukraine. Ukraine's claim to have destroyed Russian armored vehicles that had crossed the border seemed to unnerve world markets but only made the United States look more like a haven. The fact that U.S. economic data continues to portray a growing economy, while Europe looks about ready to make it a triple-dip recession, Japan reported a 6.8 percent decline in second quarter output, and new bank lending fell sharply in China to its lowest level since October 2008, added to the appeal of U.S. securities. For the week, the Dow Jones Industrial Average rose 108.98 points (0.66 percent), the S&P 500 Index advanced 23.47 points (1.22 percent), and the Nasdaq Composite gained 94.03 points (2.15 percent). Elsewhere overseas we had what these days passes for good news: a Gaza cease-fire was extended (following a brief flurry of Hamas rocket attacks and Israeli retaliation) and the Iraqi Prime Minister stepped aside providing hope that a new leader can attain sufficient unity to generate a credible response to Islamic extremists...perhaps with U.S. support.
In the News
Cree (CREE-44.00) Dimmed Light
Cree, the light-emitting diode maker, reported that fiscal fourth (June) quarter adjusted EPS of $0.42, up from $0.38 in the year-earlier period and just above the consensus estimate of $0.41 aided by a lower-than-expected tax rate. While revenue grew 16 percent to $436.3 million, this figure fell short of the average expectation of $444 million. During the period, Cree's operating margin narrowed to 7.3 percent from 8.2 percent a year earlier. Cree forecast fiscal first-quarter adjusted EPS of $0.40 to $0.45 on revenue of $440 million to $465 million. The prior average analyst estimates had been for EPS $0.46 on revenue of $469.78 million. Cree said that the LED industry has benefited from the U.S. phase-out of several varieties of incandescent light bulbs. Cree has a partnership with Home Depot (HD) to sell its consumer LED bulbs. Investors nonetheless focused on the near-term and the stock was down 11 percent for the week and now trades 42 percent below its 52-week high.
Kate Spade (KATE-31.65) Bagged
Kate Spade shares plunged on Tuesday after the Company warned on its second quarter earnings conference call that sales could slow in the second half of the year. Shares of the retailer, which initially rallied after reporting second (June) quarter EPS of $0.05 on revenue of $266 million as compared to expectations of break-even on revenue of $238 million, when the Company said sales would increase at a "high-single" digit rate in the second half of the year, down from a 30 percent gain in the first half. The Company said its profit margin goals may also be delayed by a year due to the slower than expected ramp up of Kate Spade's "Saturday" brand. Kate Spade also lowered the store expansion target to 100 stores from 134. The Company also said the wind-down of its Juicy Couture brand is "substantially complete," and that it is now reporting that segment as discontinued operations. While the stock recovered almost 10 percent from its Tuesday low, it finished the week down 17.5 percent for the week.
The Week Ahead
Once again this week, scheduled economic news should show steady, if unimpressive growth, as compared to increasingly worrisome results emanating from Europe. More than economic reports, Federal Reserve Chair Janet Yellen's keynote address at the annual Jackson Hole conference may be a market-mover. The conference this year is will focus on labor-market dynamics. Retailers will dominate this week's earnings calendar. While results are expected to be generally mixed, earnings for home improvement retailers Home Depot (HD) and Lowe's (LOW) are forecast to be up over 15 percent. The Treasury auctions scheduled for this week are on Monday: $29 billion of three-month bills and $25 billion six month bills; Tuesday: $25 billion one-year notes; and Thursday: $16 billion four-year eight-month TIPS.
| Company |
Ticker |
Sector |
Market Cap (M) |
Current Price* |
52-Week Change |
| Akers Biosciences, Inc. |
NasdaqCM: AKER |
Health Care |
$21.50 |
$4.40 |
-20% |
| Asure Software |
NasdaqCM: ASUR |
Technology |
$31.00 |
$5.18 |
14% |
| Actinium Pharmaceuticals |
NYSE MKT: ATNM |
Biotechnology |
$178.70 |
$6.35 |
15% |
| AV Therapeutics |
OTC BB: AVTH |
Biotechnology |
$4.90 |
$0.06 |
-90% |
| American Water Works |
NYSE: AWK |
Utilities |
$8.81 |
$49.25 |
25% |
| Blue Earth, Inc. |
OTC BB: BBLU |
Technology |
$235.40 |
$3.20 |
10% |
| BDCA Venture |
NasdaqCM: BDCV |
Technology |
$47.50 |
$4.85 |
-27% |
| Biocept |
NasdaqCM: BIOC |
Biotechnology |
$15.30 |
$3.44 |
-63% |
| Big North Graphite |
OTC: BNCIF |
Mining & Metals |
$3.80 |
$0.06 |
-31% |
| Craft Brew Alliance |
NasdaqGS: BREW |
Consumer Goods |
$255.60 |
$13.42 |
-1% |
| Boston Therapeutics |
OTC QB: BTHE |
Health Care |
$15.40 |
$0.40 |
-20% |
| Combimatrix Corporation |
NasdaqCM: CBMX |
Biotechnology |
$15.50 |
$1.40 |
-51% |
| Cancer Genetics, Inc. |
NasdaqCM: CGIX |
Health Care |
$81.10 |
$8.36 |
-33% |
| CNS Response Inc. |
OTCQB: CNSO |
Health Care |
$24.40 |
$0.24 |
-52% |
| Cardica |
NasdaqGM: CRDC |
Health Care |
$114.80 |
$1.29 |
3% |
| Digital Cinema Destinations |
NasdaqCM: DCIN |
Entertainment |
N/A |
$5.99 |
-2% |
| Direct Insite, Corp. |
OTC: DIRI |
Technology |
$7.00 |
$0.55 |
-62% |
| DRONE Aviation Corp |
OTCQB: DRNE |
Technology |
N/A |
$0.65 |
-41% |
| DS Laboratories |
NasdaqCM: DSKX |
Biotechnology |
$17.90 |
$1.11 |
-37% |
| Exeo Entertainment, Inc. |
OTC BB: EXEO |
Consumer Goods |
$25.10 |
$1.05 |
-8% |
| Galectin Therapeutics |
NasdaqCM: GALT |
Biotechnology |
$116.40 |
$5.28 |
-42% |
| Giggles n' Hugs |
OTC QB: GIGL |
Consumer Goods |
$18.00 |
$0.57 |
128% |
| Galaxy Gaming, Inc. |
OTC BB: GLXZ |
Consumer Goods |
$15.40 |
$0.40 |
60% |
| GlyEco |
OTC QB: GLYE |
Industrials |
$39.00 |
$0.67 |
-41% |
| Health Enhancement Products, Inc |
OTCQB: HEPI |
Biotechnology |
$16.50 |
$0.13 |
-69% |
| InterCloud Systems |
NasdaqCM: ICLD |
Technology |
$59.70 |
$4.28 |
-38% |
| iSatori |
OTC QB: IFIT |
Consumer Goods |
$15.70 |
$1.22 |
-55% |
| Inovio Pharmaceuticals |
NYSE-MKT: INO |
Biotechnology |
$617.30 |
$10.22 |
19% |
| Keating Capital |
NasdaqCM: KIPO |
Financial |
N/A |
$6.08 |
-10% |
| Local Corp. |
NasdaqCM: LOCM |
Technology |
$44.80 |
$1.93 |
-3% |
| Lightbridge |
NasdaqCM: LTBR |
Technology |
$37.50 |
$2.49 |
32% |
| Lattice, Inc. |
OTC QB: LTTC |
Technology |
$3.90 |
$0.08 |
-37% |
| Localiza Rent a Car SA |
OTC-MKT: LZRFY |
Consumer Goods |
$3.27 |
$15.70 |
6% |
| MeetMe |
NasdaqCM: MEET |
Social Media |
$89.40 |
$2.00 |
14% |
| Methes Energy |
NasdaqCM: MEIL |
Energy |
$17.30 |
$1.51 |
-42% |
| MusclePharm |
OTC QB: MSLP |
Consumer Goods |
$147.40 |
$13.25 |
30% |
| Northwest Biotherapeutics |
NasdaqCM: NWBO |
Health Care |
$324.30 |
$5.45 |
58% |
| Oragenics |
NYSE-MKT: OGEN |
Health Care |
$49.90 |
$1.38 |
-54% |
| OPKO Health |
NYSE: OPK |
Health Care |
$3.61 |
$8.42 |
-1% |
| Opexa Therapeutics |
NasdaqCM: OPXA |
Biotechnology |
$30.30 |
$1.09 |
-39% |
| OxySure Systems, Inc. |
OTC QB: OXYS |
Health Care |
$21.60 |
$0.83 |
6% |
| Profire Energy |
NasdaqCM: PFIE |
Technology |
$219.60 |
$4.18 |
78% |
| Pulse Beverage Corporation |
OTC-MKT: PLSB |
Consumer Goods |
$17.20 |
$0.33 |
-59% |
| Perceptron |
NasdaqGM: PRCP |
Technology |
$92.00 |
$10.05 |
-2% |
| Quadrant 4 Systems |
OTC QB: QFOR |
Technology |
$53.60 |
$0.54 |
75% |
| RedHill Biopharma Ltd. |
NasdaqCM: RDHL |
Health Care |
$121.50 |
$13.88 |
39% |
| Richfield Oil |
OTC QX: ROIL |
Energy |
$10.20 |
$0.17 |
-60% |
| SANUWAVE Health |
OTC BB: SNWV |
Biotechnology |
$11.70 |
$0.23 |
-68% |
| Sorrento Therapeutics |
NasdaqCM: SRNE |
Biotechnology |
$141.80 |
$4.97 |
-36% |
| StarStream Entertainment |
OTC QB: SSET |
Entertainment |
$5.00 |
$0.28 |
-94% |
| Tasman Metals |
NYSE-MKT: TAS |
Mining & Metals |
$41.80 |
$0.63 |
-25% |
| Top Ships, Inc. |
NasdaqGS: TOPS |
Industrials |
$37.20 |
$1.96 |
-85% |
| Trecora Resources |
NYSE: TREC |
Mining & Metals |
$313.40 |
$12.97 |
46% |
| Vaccinogen |
OTC: VGEN |
Biotechnology |
$124.50 |
$3.87 |
-36% |
| Vapor Corp. |
OTC QB: VPCO |
Consumer Goods |
$24.60 |
$1.49 |
-69% |
| Xplore Technologies |
NasdaqCM: XPLR |
Technology |
$44.50 |
$5.27 |
28% |
- Back to top
Recent Reports
ATNM Research Profile - Sept. 2014
Actinium Pharmaceuticals, Inc. is a New York-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The Company’s lead radiopharmaceutical Iomab™-B is indicated for preparing patients for hematopoietic stem cell transplant (HSCT), commonly referred to as bone marrow transplant.
Download Report |
Company PageGLYE Research Profile - Aug. 2014
Capacity Expansion Sets the Stage for Increased Sales Volume
Revenue increased 13% YoY. In 2Q14, GLYE reported revenue of $1.6 million, a 13% YoY increase as compared to 2Q13 revenue of $1.4 million. The revenue increase was due to increased production capabilities and entry into new markets. Gross margins were (1%) in 2Q14. The primary factor behind the low margins in 2Q14 was infrastructure investments and the transition to Type 1 (T1) refinery-grade recycled glycol at the New Jersey facility. The New Jersey facility had low production volume in 2Q14, but this is expected to accelerate going forward, leading to much higher gross margins.
Download Report |
Company PageQFOR Research Profile - Aug. 2014
qHIX Healthcare Exchange and Media Vertical are Poised to Drive Substantial Growth
2Q14 revenue increased 31% YoY; positive net income reported. QFOR continued to show strong revenue growth, with 2Q14 revenue up 31% YoY to $11.9 million. Gross profit increased 28% YoY to $3.1, EBITDA was reported at $1.7 million (17th consecutive quarter of positive EBITDA), and net income was $23,530. While we are pleased to see the strong growth this quarter, we believe the biggest focus should be on QFOR’s growth initiatives, particularly in the healthcare and media divisions.
Download Report |
Company PageLTTC Research Profile - Aug. 2014
Lattice Poised to Continue Growing Domestically and Internationally
2Q14 revenue increased 18% YoY. The primary factor in the revenue improvement was volume growth in direct telecom services to end-user correctional facilities. Taking a closer look at the revenue growth, recurring call provisioning and ancillary services were up 6% YoY, and had an increase of 11% YoY when accounting only for direct contracting to facilities.
Download Report |
Company PageAKER Research Profile - Aug. 2014
Revenue up 26% YoY, Sales & Marketing Focus to Continue Driving Revenue Growth
Revenue increased 26% YoY. In 2Q14, AKER reported revenue of $1.4 million, a 26% YoY increase as compared to 2Q13 revenue of $1.1 million. The Company also reported a robust gross margin of 89% in 2Q14. The primary factor behind the 89% gross margin was the Company's removal of the REA products from inventory in prior periods. As a result, there was no significant cost of inventory associated with the REA product sales in the period. AKER’s gross margins are expected to decline back to the 45-55% range going forward, which is in line with historic figures.
Download Report |
Company Page
About RedChip
RedChip Companies, Inc. is a well-established source of independent research and information on the small-cap markets. Dedicated to "Discovering Tomorrow's Blue Chips Today™," our analysts seek out emerging growth companies and undiscovered small-cap values before they show up on Wall Street's radar screen. RedChip analysts provide a unique breadth of coverage and depth of research on undiscovered small-cap companies.
- Back to top
